Navigation Links
High-content screening of GPCR activation with MetaXpress, AcuityXpress and the Transfluor assay system

METAXPRESS APPLICATION NOTE

By Susan Catalano, Ph.D., Acumen Pharmaceuticals, Sylvia de Bruin, Joe Bosworth, Ph.D., Neal Gliksman, Ph.D., Kimberly Best, Ph.D. and Paula Rickert, Ph.D., Molecular Devices Corporation, 1311 Orleans Drive, Sunnyvale, CA 94089.


INTRODUCTION
G-protein coupled receptors (GPCRs are the largest class of pharmaceutical targets and, as a result, assays for detecting GPCR receptor agonists and antagonists play a major role in screening operations. Recently Xsira Pharmaceuticals introduced the Transfluor assay, a novel high-content assay that monitors GPCR activation by measuring GPCR desensitization and recycling. The Transfluor assay is now exclusively available from Molecular Devices.

The Transfluor Assay, validated on over 90 different GPCRs, uses a common pathway independent of downstream G-protein signaling which is shared by virtually all GPCRs, representing all classes of GPCRs and G proteins. The assay uses image analysis to quantitate internalization of GFP-tagged beta-arrestin that associates with the receptor of interest following activation.1 (See Figure 1.)


HIGH-CONTENT SCREENING OF GPCR ACTIVATION WITH METAXPRESS, ACUITYXPRESS AND THE TRANSFLUOR ASSAY SYSTEM

Unstimulated cells display diffuse cytoplasmic beta-arrestin-GFP fluorescence. When an over-expressed GPCR is activated, beta-arrestin targets the receptor for internalization, resulting in the appearance of small fluorescent clathrin-coated pits. If the receptor has a high affinity for beta-arresti
'"/>

Source:


Page: All 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. siRNA screening of the cell cycle with two dynamic GFP sensors (from Discovery Matters Issue 1, July 2005)
2. Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3, 5 monophosphate and its validation for pharmacological screening at G protein-coupled receptors
3. Cell lines expressing recombinant aequorin and a G-protein coupled receptor for functional screening
4. Inactivation of Contaminating Templates in PCR Using High Intensity Ultraviolet Light
5. Enzyme Immunoassay for Studying Intracellular Levels of cAMP
6. LiquiChip Kits for bead-based cytokine and kinase assays
7. Quality control of antibodies using the 2100 bioanalyzer and the Protein 200 Plus assay
8. Bio-Plex Cytokine Immunoassays and ELISA: Comparison of Two Methodologies in Testing Samples From Asthmatic and Healthy Children, Rev A
9. Principles of Curve Fitting for Multiplex Sandwich Immunoassays, Rev B
10. The development of a CXCR2 chemokine receptorbinding assay using the LEADseeker Multimodality Imaging System
11. Is Z factor the best assessment for the quality of cellular assays delivering higher content?

Post Your Comments:
(Date:11/24/2009)...s been met for patients with advanced-stage, or... Nov. 24 /PRNewswire-FirstCall/ - AEterna Zentaris...a global biopharmaceutical company focused on endo...ve efficacy data from a Phase 2 study with its tar...rly AN-152), in patients with advanced or recurren...
(Date:11/24/2009)...wswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (... is scheduled to present at the Piper Jaffray 21st... at 11:30 a.m. Eastern Time (8:30 a.m. Pacific Tim...Jack Lief, Arena,s President and Chief Executive O... company, including its clinical development and d...
(Date:11/24/2009)...tomers with Partners Validated to Process and Anal... Ottawa, ON (PRWEB) Novemb...f products for biological sample collection, stabi...global partner program. The program offers signifi...ity and is designed to help partners scale and dif...
(Date:11/23/2009)...tive new study, a University of Utah scientist arg...r cause of global warming cannot be stabilized un...ds the equivalent of one new nuclear power plant e...e any substantial near-term departure from recentl... rates," says the new paper by Tim Garrett, an ass...
Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4
...iences,(Nasdaq: MATK ) announced today the launch...s patented, vegetarian form of DHA omega-3 for bra...bread with vegetarian DHA,Oroweat 9 Grain Bread wi...ble at major retailers in the Pacific Northwest, C...from Bimbo Bakeries demonstrates the broad range o...
...ernational Inc. (NYSE: BAX ) announced today that...e of an additional $2 billion of the company,s,com...mpany,s existing share,repurchase authorization., ...thorization under its,previous $2 billion share re.... Shares will be repurchased in the open market at...
...es Therapeutics,Inc. (Nasdaq: TPTX ) today announ... muscarinic agonist in development for xerostomia,...he company is conducting a randomized, double-blin...n square design to evaluate,the safety, tolerabili...ximately 24 patients will be enrolled at three sit...
Other Biology Technology:Martek Announces Launch of Oroweat 9 Grain Bread, First Bread with Martek's life'sDHA 2Martek Announces Launch of Oroweat 9 Grain Bread, First Bread with Martek's life'sDHA 3Baxter's Board of Directors Approves New Share Repurchase Authorization of $2 Billion 2TorreyPines Therapeutics Initiates Phase II Study of Muscarinic Agonist NGX267 for Treatment of Xerostomia 2TorreyPines Therapeutics Initiates Phase II Study of Muscarinic Agonist NGX267 for Treatment of Xerostomia 3TorreyPines Therapeutics Initiates Phase II Study of Muscarinic Agonist NGX267 for Treatment of Xerostomia 4
(Date:11/24/2009)...s to understanding how sounds associated with Navy... or if they hear it at all. , The same type of ...es to detect flaws in the space shuttle,s behemoth...peek inside the giant head of a whale. The scans a...f a whale,s hearing anatomy using a breakthrough m...
(Date:11/24/2009)...kable class of ring-shaped protein motors has been...ey National Laboratory (Berkeley Lab) using a stat...he Advanced Light Source (ALS). These protein moto...cation, and are vital to the survival of all biolo... the human papillomavirus, which has been linked t...
(Date:11/24/2009)... held secrets of the earth,s history locked in its...ry little information on the environments that hav... years. Now, a team of researchers from nine insti...ne of $10 million dollars by the National Science ... literally. These scientists will drill through t...
Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4LSU gets to the bottom of things -- in Antarctica 2Researchers begin to decipher metabolism of sexual assault drug 10831 1Researchers begin to decipher metabolism of sexual assault drug 10831 2Leahy Will Vote to End Health Bill Filibuster Plans to Offer Amendment to End Health Insurers Antitrust Exemption 61782 1Warner Chilcott Prices Secondary Equity Offering 6425 1Warner Chilcott Prices Secondary Equity Offering 6425 2Warner Chilcott Prices Secondary Equity Offering 6425 3Warner Chilcott Prices Secondary Equity Offering 6425 4
...can Society for Microbiology (ASM) Siemens Healthc...presented to Adrian M. Zelazny, Staff Scientist, L...National Institutes of Health (NIH). This award re...microbiology or antimicrobial therapy. , Dr. Zela...ceptibility and resistance, microbial virulence, a...
...ion of biosolids (treated municipal sewage sludge)... source of plant nutrients and organic matter. How... in biosolids led to concerns that farmland applic...l and their subsequent translocation through the h...ns have extremely high bioaccumulation potential. ...
...c and professional organization of more than 16,00...lications, technology and science of molecular ima...esearch grants to support molecular imaging resear...esearch Foundation, represent the society,s commit... supporting the next generation of researchers. ,...
Other Biology News:Dioxin risk in soil and plant tissues after long-term biosolids application 2SNM awards $300,000 to support molecular imaging research 2
...0 (CYP450) metabolite postulated to play an autaco...rat cerebral microvessels, 20-HETE is a vasoconstr...y vasoconstriction. 20-HETE is excreted mainly as ...ee 20-HETE (20-40 pg/ml in human urine) is about 1...
...m enables you to insert a transposable element of ... transposition. It uses TnsABC* Transposase to ins... target. Target DNA may be a plasmid, cosmid, BAC ...nterests (6-8). If the insertion site is within a ...
Peptide Standards from New England Biolabs
CORNING CELLSTACK VENTED CAP, 33MM, STERILE, 0.2UM MEMBRANE from Sigma-Aldrich
Biology Products: